- Plant-based recombinant COVID-19 vaccine found to be effective. Researchers found vaccine efficacy was 78.8 and 74.0 per cent against moderate-to-severe disease and among those who were seronegative at the start, respectively https://www.nejm.org/doi/10.1056/NEJMoa2201300 2 comments science
Linking pages
Linked pages
- WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data https://covid19.who.int/ 23 comments
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2035389 18 comments
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2107659?query=featured_home 4 comments
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2104840 0 comments
- VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208822 0 comments
Related searches:
Search whole site: site:www.nejm.org
Search title: Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine | NEJM
See how to search.